Activity Report 2017

CIC bioGUNE - Centro de Investigación Cooperativa en Biociencias

 

About Us

flecha abajo-derecha

Mission:

Conducting research of excellence in the life sciences, covering all areas of R&D&i, including technology transfer and commercial exploitation exploitation of our science.

flecha derecha-abajo

Strategic Challenges:

  • Research Excellence
  • Technology Transfer
  • Collaboration with RVCTI agents
  • International recognition
  • Training and promotion of research talent
  • Attraction and retention of talent
  • Communication and Outreach
  • Excellence in Management

Strategy:

Commitment to specialization and excellence

flecha derecha-arriba

Competitiveness:

  • Leading infrastructures
  • Human Resources
  • Technical and administrative support
  • Competitive salaries
  • Goal-Fulfillment Incentives
flecha abajo-izquierda

Staff 2017

Staff 2017.12.31: 0 181

Average Age: 0 37.5 years

Permanent staff: 0 50 %

  • 0 55.2% Female
    100
  • 0 44.8% Male
    81

181 Total CIC bioGUNE Personnel

  • 0 84% Research
    152
  • 0 16% Administration and services
    29

 

Research distribution by Professional Category

    % Woman Man
  Researchers 106 69.7 50 56
  • Principal investigators/Platform Managers 25 16.4 7 18
  • Posdoctoral Researches/Research Assistant 40 26.3 19 21
  • PhD Student 41 27.0 24 17
  Technicians 46 30.3 34 12

Researcher distribution by origin

Researcher distribution by Origin

Spain 82
Italy 6
Portugal 1
Austria 2
United Kingdom 2
Holland 1
Albania 1
Germany 2
Czech Republic 1
America 6
Asia 2
  • 0 77.36% Spanish
    82 researchers
  • 0 15.09% Rest of Europe
    16 researchers
  • 0 5.06% America
    6 researchers
  • 0 1.89% Asia
    2 researchers

New Lab

Alberto Fernández- Tejada
Group Leader
University of Oxford, UK

Chemical Immunology Lab

Research lines

  • Synthesis
  • Biological evaluation
  • Immunological studies of glycoconjugates

* Alberto Fernández- Tejada (Logroño, Spain, 1982) graduated with a degree in Chemistry at the University of La Rioja (2004), where he also obtained his PhD in 2009 under the supervision of Prof. Jesús M. Peregrina and Dr. Francisco Corzana. In 2010, he pursued postdoctoral studies at Memorial Sloan Kettering Cancer Center (MSKCC, New York) in the laboratory of the late Prof. David Y. Gin funded by the Spanish Ministry of Education with the sponsorship of the Fulbright Commission. Then, he continued working at MSKCC supervised by Prof. Samuel J. Danishefsky as a Marie Curie International Outgoing Fellow. In 2014, he moved back to Spain to work with Prof. Jesús Jiménez-Barbero as part of the reintegration phase of his current Marie Curie Fellowship to leave in September 2015 to Oxford with a new MSCA grant.

Training

0 Prácticas formativas de Grado

0 Trabajos Fin de Grado

0 Erasmus

0 Trabajos Fin de Máster

0 Formación Profesional

0 Certificado de Profesionalidad

Funding 2017

Total 2017 R&D Budget: 0 million €

N. R&D Projects: 0

 
  • 0 % Public Funding
    51,32% competitive + 48,68% non-competitive
  • 0 % Private Funding
  • 0 % Basque Government Departments
    6.057 K€
  • 0 % MINECO & MEDC (Spanish Government)
    2.533 K€
  • 0 % R&D Contracts, Research Services & Others
    1.376 K€
  • 0 % EU & International Projects
    1.040 K€

Center of Excellence Severo Ochoa

The “Center of Excellence Severo Ochoa” Award, within the subprogram of Institutional Strengthening of the State Plan for Scientific and Technical Research and Innovation, aims to fund and accredit public research centers and units in any areas that demonstrate scientific leadership and have global impact, as well as active collaborations in their social and business environments.

The Centers of Excellence Severo Ochoa are organizational structures with highly competitive strategic research programmes at the frontiers of knowledge. They are among the best in the world in their respective scientific areas.

Scientific Production

 

Publications

 

Citations

First Quartile

First Decile

IF > 10

Collaborations RVCTI 2017

Research Programmes

Metabolism and Cell Signaling in Disease

  • Personalized medicine
  • Prostate Cancer
  • Breast Cancer
  • Colorectal Cancer
  • Liver Diseases
  • Rare Diseases
  • Biomarkers for Diagnosis
  • Biomarkers for Prognosis
  • Drug Design and Discovery

Molecular Recognition and Host-Pathogen

  • Rare Diseases
  • Homeostasis
  • Viral Infections
  • Bacterial Infections
  • Prion Disease
  • Tick-Borne Disease
  • Immune Response
  • Drug Design and Discovery

Platforms

  • NMR Spectroscopy
  • Macromolecular Crystallography
  • Electron Microscopy
  • Genome Analysis
  • Proteomics
  • Metabolomics
  • Animal Facility

Generation of
knowledge

Technology
transfer

Commercialization of
results


The Research Programmes
Metabolism & Cell Signaling in Disease

Brain

Breast

Colon

Liver

Prostate

  1. Target discovery and evaluation of therapeutic potential
  2. Cancer and more: Identification of biomarkers with potential diagnostic value
  3. Novel therapies against rare diseases
  4. The molecular basis of fibrosis
  5. Nonalcoholic steatohepatitis
Human cells and animal models of disease

The Research Programmes
Molecular Recognition & Host-Pathogen Interactions

Parasites

Vaccines

Antibiotics

Membrane remodelling

Animal and plant viruses

  1. Bacterial and Viral Infections: Vaccines for human and animal health
  2. Mechanisms of membrane remodelling during microbial invasion and propagation
  3. Plant vaccines and transgenics
  4. Antibiotics research and molecular characterization

The Research Programmes
Technology Platforms

Genome Analysis Platform

Proteomics Platform

Metabolomics Platform

Animal Facility

Antibodies Production

Drug Repositioning & Discovery

Nuclear Magnetic Resonance

Macromolecular Crystallography

Electron Microscopy Platform

Collaboration Models

Services
R&D Collaborations
Consulting

Highlights

mTORC1-dependent AMD1 regulation sustains polyamine metabolism in prostate cancer

Zabala-Letona A, Arruabarrena-Aristorena A, Martín-Martín N, Fernandez-Ruiz S, Sutherland JD, Clasquin M, Tomas-Cortazar J, Jimenez J, Torres I, Quang P, Ximenez-Embun P, Bago R, Ugalde-Olano A, Loizaga-Iriarte A, Lacasa-Viscasillas I, Unda M, Torrano V, Cabrera D, van Liempd SM, Cendon Y, Castro E, Murray S, Revandkar A, Alimonti A, Zhang Y, Barnett A, Lein G, Pirman D, Cortazar AR, Arreal L, Prudkin L, Astobiza I, Valcarcel-Jimenez L, Zuñiga-García P, Fernandez-Dominguez I, Piva M, Caro-Maldonado A, Sánchez-Mosquera P, Castillo-Martín M, Serra V, Beraza N, Gentilella A, Thomas G, Azkargorta M, Elortza F, Farràs R, Olmos D, Efeyan A, Anguita J, Muñoz J, Falcón-Pérez JM, Barrio R, Macarulla T, Mato JM, Martinez-Chantar ML, Cordon-Cardo C, Aransay AM, Marks K, Baselga J, Tabernero J, Nuciforo P, Manning BD, Marjon K, Carracedo A.

Nature. 2017 Jul 6;547(7661):109-113. doi: 10.1038/nature22964.

Metabolomic Identification of Subtypes of Nonalcoholic Steatohepatitis

Alonso C, Fernández-Ramos D, Varela-Rey M, Martínez-Arranz I, Navasa N, Van Liempd SM, Lavín Trueba JL, Mayo R, Ilisso CP, de Juan VG, Iruarrizaga-Lejarreta M, delaCruz-Villar L, Mincholé I, Robinson A, Crespo J, Martín-Duce A, Romero-Gómez M, Sann H, Platon J, Van Eyk J, Aspichueta P, Noureddin M, Falcón-Pérez JM, Anguita J, Aransay AM, Martínez-Chantar ML, Lu SC, Mato JM

Gastroenterology. 2017 May;152(6):1449-1461.e7. doi: 10.1053/j.gastro.2017.01.015.

dfdsf

Hypothalamic AMPK-ER Stress-JNK1 Axis Mediates the Central Actions of Thyroid Hormones on Energy Balance

Martínez-Sánchez N, Seoane-Collazo P, Contreras C, Varela L, Villarroya J, Rial-Pensado E, Buqué X, Aurrekoetxea I, Delgado TC, Vázquez-Martínez R, González-García I, Roa J, Whittle AJ, Gomez-Santos B, Velagapudi V, Tung YCL, Morgan DA, Voshol PJ, Martínez de Morentin PB, López-González T, Liñares-Pose L, Gonzalez F, Chatterjee K, Sobrino T, Medina-Gómez G, Davis RJ, Casals N, Orešič M, Coll AP, Vidal-Puig A, Mittag J, Tena-Sempere M, Malagón MM, Diéguez C, Martínez-Chantar ML, Aspichueta P, Rahmouni K, Nogueiras R, Sabio G, Villarroya F, López M.

Cell Metab. 2017 Jul 5;26(1):212-229.e12. doi: 10.1016/j.cmet.2017.06.014.

Quiescence-like Metabolism to Push Cancer Out of the Race

Torrano V, Carracedo A.

Cell Metab. 2017 May 2;25(5):997-999. doi: 10.1016/j.cmet.2017.04.027.

The Use of Fluoroproline in MUC1 Antigen Enables Efficient Detection of Antibodies in Patients with Prostate Cancer

Somovilla VJ, Bermejo IA, Albuquerque IS, Martínez-Sáez N, Castro-López J, García-Martín F, Compañón I, Hinou H, Nishimura SI, Jiménez-Barbero J, Asensio JL, Avenoza A, Busto JH, Hurtado-Guerrero R, Peregrina JM, Bernardes GJL, Corzana F.

J Am Chem Soc. 2017 Dec 20;139(50):18255-18261. doi: 10.1021/jacs.7b09447.

Calibration-Free Electrochemical Biosensors Supporting Accurate Molecular Measurements Directly in Undiluted Whole Blood

Li H, Dauphin-Ducharme P, Ortega G, Plaxco KW.

J Am Chem Soc. 2017 Aug 16;139(32):11207-11213. doi: 10.1021/jacs.7b05412

dfdsf

Contribution of Shape and Charge to the Inhibition of a Family GH99 endo-α-1,2-Mannanase

Petricevic M, Sobala LF, Fernandes PZ, Raich L, Thompson AJ, Bernardo-Seisdedos G, Millet O, Zhu S, Sollogoub M, Jiménez-Barbero J, Rovira C, Davies GJ, Williams SJ.

J Am Chem Soc. 2017 Jan 25;139(3):1089-1097. doi: 10.1021/jacs.6b10075

Role of Aramchol in steatohepatitis and fibrosis in mice

Iruarrizaga-Lejarreta M, Varela-Rey M, Fernández-Ramos D, Martínez-Arranz I, Delgado TC, Simon J, Juan VG, delaCruz-Villar L, Azkargorta M, Lavin JL, Mayo R, Van Liempd SM, Aurrekoetxea I, Buqué X, Cave DD, Peña A, Rodríguez-Cuesta J, Aransay AM, Elortza F, Falcón-Pérez JM, Aspichueta P, Hayardeny L, Noureddin M, Sanyal AJ, Alonso C, Anguita J, Martínez-Chantar ML, Lu SC, Mato JM.

Hepatol Commun. 2017 Nov;1(9):911-927. doi: 10.1002/hep4.1107.

Serum extracellular vesicles contain protein biomarkers for primary sclerosing cholangitis and cholangiocarcinoma

Arbelaiz A, Azkargorta M, Krawczyk M, Santos-Laso A, Lapitz A, Perugorria MJ, Erice O, Gonzalez E, Jimenez-Agüero R, Lacasta A, Ibarra C, Sanchez-Campos A, Jimeno JP, Lammert F, Milkiewicz P, Marzioni M, Macias RIR, Marin JJG, Patel T, Gores GJ, Martinez I, Elortza F, Falcon-Perez JM, Bujanda L, Banales JM.

Hepatology. 2017 Oct;66(4):1125-1143. doi: 10.1002/hep.29291.

MicroRNA-506 promotes primary biliary cholangitis-like features in cholangiocytes and immune activation

Erice O, Munoz-Garrido P, Vaquero J, Perugorria MJ, Fernandez-Barrena MG, Saez E, Santos-Laso A, Arbelaiz A, Jimenez-Agüero R, Fernandez-Irigoyen J, Santamaria E, Torrano V, Carracedo A, Ananthanarayanan M, Marzioni M, Prieto J, Beuers U, Oude Elferink RP, LaRusso NF, Bujanda L, Marin JJG, Banales JM.

Hepatology. 2018 Apr;67(4):1420-1440. doi: 10.1002/hep.29533.

dfdsf

Prohibitin 1 suppresses liver cancer tumorigenesis in mice and human hepatocellular and cholangiocarcinoma cells

Fan W, Yang H, Liu T, Wang J, Li TW, Mavila N, Tang Y, Yang J, Peng H, Tu J, Annamalai A, Noureddin M, Krishnan A, Gores GJ, Martínez-Chantar ML, Mato JM, Lu SC.

Hepatology. 2017 Apr;65(4):1249-1266. doi: 10.1002/hep.28964.

Deregulated neddylation in liver fibrosis

Zubiete-Franco I, Fernández-Tussy P, Barbier-Torres L, Simon J, Fernández-Ramos D, Lopitz-Otsoa F, Gutiérrez-de Juan V, de Davalillo SL, Duce AM, Iruzubieta P, Taibo D, Crespo J, Caballeria J, Villa E, Aurrekoetxea I, Aspichueta P, Varela-Rey M, Lu SC, Mato JM, Beraza N, Delgado TC, Martínez-Chantar ML.

Hepatology. 2017 Feb;65(2):694-709. doi: 10.1002/hep.28933.

dfdsf

SOX17 regulates cholangiocyte differentiation and acts as a tumor suppressor in cholangiocarcinoma

Merino-Azpitarte M, Lozano E, Perugorria MJ, Esparza-Baquer A, Erice O, Santos-Laso Á, O'Rourke CJ, Andersen JB, Jiménez-Agüero R, Lacasta A, D'Amato M, Briz Ó, Jalan-Sakrikar N, Huebert RC, Thelen KM, Gradilone SA, Aransay AM, Lavín JL, Fernández-Barrena MG, Matheu A, Marzioni M, Gores GJ, Bujanda L, Marin JJG, Banales JM.

J Hepatol. 2017 Jul;67(1):72-83. doi: 10.1016/j.jhep.2017.02.017. Epub 2017 Feb 22. PubMed PMID: 28237397; PubMed Central PMCID: PMC5502751.  

The mitochondrial negative regulator MCJ is a therapeutic target for acetaminophen-induced liver injury

Barbier-Torres L, Iruzubieta P, Fernández-Ramos D, Delgado TC, Taibo D, Guitiérrez-de-Juan V, Varela-Rey M, Azkargorta M, Navasa N, Fernández-Tussy P, Zubiete-Franco I, Simon J, Lopitz-Otsoa F, Lachiondo-Ortega S, Crespo J, Masson S, McCain MV, Villa E, Reeves H, Elortza F, Lucena MI, Hernández-Alvarez MI, Zorzano A, Andrade RJ, Lu SC, Mato JM, Anguita J, Rincón M, Martínez-Chantar ML.

Nat Commun. 2017 Dec 12;8(1):2068. doi: 10.1038/s41467-017-01970-x. PubMed PMID: 29233977; PubMed Central PMCID: PMC5727217.

dfdsf

The interdomain flexible linker of the polypeptide GalNAc transferases dictates their long-range glycosylation preferences

de Las Rivas M, Lira-Navarrete E, Daniel EJP, Compañón I, Coelho H, Diniz A, Jiménez-Barbero J, Peregrina JM, Clausen H, Corzana F, Marcelo F, Jiménez-Osés G, Gerken TA, Hurtado-Guerrero R.

Nat Commun. 2017 Dec 5;8(1):1959. doi: 10.1038/s41467-017-02006-0. PubMed PMID: 29208955; PubMed Central PMCID: PMC5716993.  

Rules of engagement between αvβ6 integrin and foot-and-mouth disease virus.

Kotecha A, Wang Q, Dong X, Ilca SL, Ondiviela M, Zihe R, Seago J, Charleston B, Fry EE, Abrescia NGA, Springer TA, Huiskonen JT, Stuart DI.

Nat Commun. 2017 May 23;8:15408. doi: 10.1038/ncomms15408. PubMed PMID: 28534487; PubMed Central PMCID: PMC5457520.

Identification and characterization of a heterotrimeric archaeal DNA polymerase holoenzyme.

Yan J, Beattie TR, Rojas AL, Schermerhorn K, Gristwood T, Trinidad JC, Albers SV, Roversi P, Gardner AF, Abrescia NGA, Bell SD. eregrina JM, Clausen H, Corzana F, Marcelo F, Jiménez-Osés G, Gerken TA, Hurtado-Guerrero R.

Nat Commun. 2017 May 2;8:15075. doi: 10.1038/ncomms15075. PubMed PMID: 28462924; PubMed Central PMCID: PMC5418573.  

Hepatic p63 regulates steatosis via IKKβ/ER stress

Porteiro B, Fondevila MF, Delgado TC, Iglesias C, Imbernon M, Iruzubieta P, Crespo J, Zabala-Letona A, Fernø J, González-Terán B, Matesanz N, Hernández-Cosido L, Marcos M, Tovar S, Vidal A, Sánchez-Ceinos J, Malagon MM, Pombo C, Zalvide J, Carracedo A, Buque X, Dieguez C, Sabio G, López M, Aspichueta P, Martínez-Chantar ML, Nogueiras R.

Nat Commun. 2017 May 8;8:15111. doi: 10.1038/ncomms15111. Erratum in: Nat Commun. 2017 Jun 16;8:16059. PubMed PMID: 28480888; PubMed Central PMCID: PMC5424198.

Molecular mechanism of Gαi activation by non-GPCR proteins with a Gα-Binding and Activating motif.

de Opakua AI, Parag-Sharma K, DiGiacomo V, Merino N, Leyme A, Marivin A, Villate M, Nguyen LT, de la Cruz-Morcillo MA, Blanco-Canosa JB, Ramachandran S, Baillie GS, Cerione RA, Blanco FJ, Garcia-Marcos M.

Nat Commun. 2017 May 18;8:15163. doi: 10.1038/ncomms15163. PubMed PMID: 28516903; PubMed Central PMCID: PMC5454376.  

Structural basis of human PCNA sliding on DNA

De March M, Merino N, Barrera-Vilarmau S, Crehuet R, Onesti S, Blanco FJ, De Biasio A.

Nat Commun. 2017 Jan 10;8:13935. doi: 10.1038/ncomms13935

Structural Snapshots of α-1,3-Galactosyltransferase with Native Substrates: Insight into the Catalytic Mechanism of Retaining Glycosyltransferases

Albesa-Jové D, Sainz-Polo MÁ, Marina A, Guerin ME.

Angew Chem Int Ed Engl. 2017 Nov 20;56(47):14853-14857. doi: 10.1002/anie.201707922.

Breaking the Limits in Analyzing Carbohydrate Recognition by NMR Spectroscopy: Resolving Branch-Selective Interaction of a Tetra-Antennary N-Glycan with Lectins

Canales A, Boos I, Perkams L, Karst L, Luber T, Karagiannis T, Domínguez G, Cañada FJ, Pérez-Castells J, Häussinger D, Unverzagt C, Jiménez-Barbero J.

Angew Chem Int Ed Engl. 2017 Nov 20;56(47):14987-14991. doi: 10.1002/anie.201709130.

RsgA couples the maturation state of the 30S ribosomal decoding center to activation of its GTPase pocket

López-Alonso JP, Kaminishi T, Kikuchi T, Hirata Y, Iturrioz I, Dhimole N, Schedlbauer A, Hase Y, Goto S, Kurita D, Muto A, Zhou S, Naoe C, Mills DJ, Gil-Carton D, Takemoto C, Himeno H, Fucini P, Connell SR.

Nucleic Acids Res. 2017 Jun 20;45(11):6945-6959. doi: 10.1093/nar/gkx324.

Structure of a 30S pre-initiation complex stalled by GE81112 reveals structural parallels in bacterial and eukaryotic protein synthesis initiation pathways

López-Alonso JP, Fabbretti A, Kaminishi T, Iturrioz I, Brandi L, Gil-Carton D, Gualerzi CO, Fucini P, Connell SR.

Nucleic Acids Res. 2017 Feb 28;45(4):2179-2187. doi: 10.1093/nar/gkw1251.

Mitochondrial Metabolism: Yin and Yang for Tumor Progression.

Valcarcel-Jimenez L, Gaude E, Torrano V, Frezza C, Carracedo A.

Trends Endocrinol Metab. 2017 Oct;28(10):748-757. doi: 10.1016/j.tem.2017.06.004

Highlights
Editorial Activity

  • Oscar Millet
    Associate Editor

  • Joaquín Castilla
    Advisory Board

  • Juan M. Falcón-Pérez
    Advisory Board

  • Juan M. Falcón-Pérez
    Review Editor

  • Juan M. Falcón-Pérez
    Advisory Board

  • Juan M. Falcón-Pérez
    Review Editor

  • Jesús Jiménez Barbero
    Editor Board

  • Jesús Jiménez Barbero
    Editor Board

  • Juan Anguita
    Advisory Board

  • Rosa Barrio
    Editor Board

  • Aitor Hierro
    Review Editor

  • Aitor Hierro
    Review Editor

  • Félix Elortza
    Review Editor

  • Aitor Hierro
    Review Editor

  • Aitor Hierro
    Review Editor

  • Jesús Jiménez Barbero
    Editorial Board

  • Jesús-Jiménez-Barbero
    Editor Board

  • María del Mar Vivanco
    Editorial Board

  • Jesús Jiménez Barbero
    Editor Board

  • Jesús Jiménez Barbero
    Editor Board

  • Jesús Jiménez Barbero
    Editor Board

  • Edurne Berra
    Associate Editor

Scientific Output
Highlights

CIC bioGUNE researchers publish more than 150 publications. 25% of them have an Impact Factor above 10. The average IF in 2017 reaches 7.

A new research group (Chemical Imunology) joins CIC bioGUNE.

Atlas Molecular Pharma, a spin-off company from CIC bioGUNE achieves Orphan Drug Designation for its first molecular entity for Congenital Erythropoietic Porphyria.

Competitive funding at CIC bioGUNE reaches 55% of total funding.

CIC bioGUNE researchers obtain four new International projects in 2017.

CIC bioGUNE is recognized with the Severo Ochoa distinction as a Center of Excellence.

CIC bioGUNE Electron Microscopy is awarded with long-term programme Access at eBIC-diamond.

Prof. Richard Henderson member of the Scientific Advisory Board of CIC bioGUNE is awarded with the Nobel Prize in Chemistry.

Awards and Recognitions

  • Cadena SER Radio Bilbao

    Arkaitz Carracedo galardonado con el premio Radio Bilbao a la Excelencia 2017 en la categoría de investigación
  • Cadena SER Radio Bilbao  - Premios a la excelencia, Arkaitz Carracedo de CIC Biogune
  • Cadena SER Radio Bilbao  - Premios a la excelencia, Arkaitz Carracedo de CIC Biogune
  • Constantes y Vitales

    Arkaitz Carracedo galardonado con el Premio Constantes y Vitales a joven talento en investigación biomédica
  • Premio Constantes y Vitales a Arkaitz Carracedo
  • Premio Constantes y Vitales - foto de los premiados
  • European Academy of Sciences

    Jesús Jiménez Barbero ha sido designado nuevo miembro de la European Academy of Sciences (EURASC)
  • Jesús Jiménez Barbero ha sido designado nuevo miembro de la European Academy of Sciences (EURASC)
  • Premios Nobel

    El Nobel premia a dos científicos químicos vinculados al CIC bioGUNE
  • El Nobel premia a dos científicos químicos vinculados al CIC bioGUNE
  • AUSE - Asociación de Usuarios de Sincrotrón de España

    June Ereño Orbea, premio a la mejor tesis defendida en 2015/2016 por AUSE (Asociación de Usuarios de Sincrotrón de España) - octubre 2017.
  • June Ereño Orbea, premio a la mejor tesis defendida en 2015/2016 por AUSE (Asociación de Usuarios de Sincrotrón de España)
  • Hungarian Chemical Society

    La Sociedad Química de Hungría ha galardonado a Jesús Jiménez Barbero, director científico de CIC bioGUNE, con el Premio Gamboa-Winkler
  • La Sociedad Química de Hungría ha galardonado a Jesús Jiménez Barbero, director científico de CIC bioGUNE con el Premio Gamboa-Winkler
  • Premio Gamboa-Winkler

Technology transfer and innovation 2017

New Patent Applications: 0

New Collaboration Agreements: 0

New Research Contracts: 0

Economic Activity: 0

0 new Spanish Patent: 0(9)

0 Licensed Patents

Customer Base:

  • Basque Country: 0 %
  • National: 0 %
  • International: 0 %
 

7 New Patent Applications

 
  • 0 European Patent Application
  • 0 PCT Patent Application

NEBT: Atlas Molecular Pharma S.L.

NEBT: Atlas Molecular Pharma S.L.

European Medicines Agency
  • Date of qualification: 11 September 2017  
  • EMA-SME number: EMA/SME/354/17
  • Expiry of SME status: 31 December 2018
  • Customer account number : 0000607887
  • Size/Type of enterprise: Micro/Autonomous

European Medicines Agency

EMA/OD/186/17 (UPI-278)

Presentación Septiembre 2017

FDA
En trámite

Horizon 2020

Types of Action:

  • SME-1 SME Instrument phase 1
  • SME-2 SME Instrument phase 2

Deadline Model: Multiple cut-off

2018 Cut-off date: February 2018

Resolución (Favorable)

POCTEFA    Interreg Poctefa

 

Torres - Quevedo    Ministerio de economía y competitividad

En evaluación

Berrikertu    Eusko Jaurlaritza - Gobierno Vasco

 

Creación de empresas innovadoras    Diputación Foral de Bizkaia

Contratación de personal

Gráfico 
contratación de personal

Technology Transfer

 

Grupo de Investigación Traslacional

Vitoria, 19/07/2017

Theses

53 theses in progress

Codirected RVCTI

0 RVCTI

0 Theses under negociation

Activities 2017

Activities
Special Lectures

12th anniversary-lecture

Prof. Christian Griesinger
CIC bioGUNE 12th anniversary-lecture

Cáncer: Con otra mirada

Prof. Bart Vanhaesebroeck & Prof. Johan Hyllner
Lecture - Cáncer: Con otra mirada

Christmas Lecture

Prof. Aitor Hierro
Christmas Lecture

Activities
Conferences / Symposium

Frontiers in Biomolecular NMR Conference

Congreso SEBD - Joint Congress

1º Aseica Educational Symposium

Activities
Workshops/Courses

Practical Workshop - Bioinformatics Tools to study exosomes' effects

1º first Euskadi Workshop on Exosomes

Translating innovation from Academia to Society in Biological Sciences

3rd basic course in Proteomics

Introducción a Tissue Maldi Imaging mass spectometry

VIII Reunión científica sobre proteómica clínica

Activities
Seminars/meetings

1st Glycobasque Meeting Program

Jornada - Perspectivas de futuro en una carrera de biomedicina

0 speakers from Europe

0 speakers from overseas

0 speakers from Spain

0 bioGUNE PIs & PMs

0 bioGUNE PhDs Students

Dissemination & Outreach

Dissemination and Outreach
Press clippings

Dissemination & Outreach
Radio

  • José M Mato. Intervenciones periódicas
  • Arkaitz Carracedo “Apoyo Europeo a su investigación “Proof of Concept”, “Premio Excelencia 2017 en la categoría de investigación”, “Estudio publicado en Nature”
  • Malu Martínez “Publicación Hepatology” y “Día Internacional de la investigación sobre cáncer”
  • Joaquín Castilla “Insomnio familiar letal” y “Envejecimiento”
  • José M Mato, Óscar Millet y Joaquín Castilla “Día de las enfermedades raras”
  • José M Mato y Nicola Abrescia “Riesgos de la biología sintética” y “La vacuna de la gripe”
  • Felix Elortza, Xabier Agirrezabala y Óscar Millet “Concesión del Nobel a Joachim Frank y Richard Henderson”
  • Juan Anguita “Consorcio ANtiDotE”
  • Óscar Millet “Utilización de cerebro, sangre y tejidos en investigación”
  • María Vivanco “IV Carrera Solidaria” ACAMBI

Dissemination & Outreach
TV

  • Malu Martínez “Publicación Hepatology”
  • Arkaitz Carracedo “Premio Joven Talento en Investigación”
  • Joaquín Castilla “Insomnio familiar letal” y “Reunión con familiares de afectados por una enfermedad priónica”
  • Mikel Valle y Xavier Agirrezabala “Concesión del Nobel a Joachim Frank y Richard Henderson”
  • María Vivanco “IV Carrera Solidaria” ACAMBI

Dissemination and Outreach
We have also participated in...

Download PDF version Previous Report (2016)